Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity - Restricted Stock (Details)

v3.22.1
Stockholders' Equity - Restricted Stock (Details) - Unvested restricted stock
3 Months Ended
Mar. 31, 2022
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Number of shares, Nonvested beginning balance | shares 4,512,701
Number of shares, Granted | shares 968,500
Number of Shares, Forfeited | shares (50,000)
Number of shares, Vested | shares (1,984,610)
Number of shares, Nonvested ending balance | shares 3,446,591
Weighted Average Exercise Price, Nonvested beginning balance | $ / shares $ 3.35
Weighted Average Grant Date Fair Value, Granted | $ / shares 2.53
Weighted Average Grant Date Fair Value, Forfeited | $ / shares 2.53
Weighted Average Grant Date Fair Value, Vested | $ / shares 3.67
Weighted Average Exercise Price, Nonvested ending balance | $ / shares $ 2.95